Man And Woman Admit To Their Roles In Synthetic Drug Distribution That Lead To An Overdose Death
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Man And Woman Admit To Their Roles In Synthetic Drug Distribution That Lead To An Overdose Death

Man And Woman Admit To Their Roles In Synthetic Drug Distribution That Lead To An Overdose Death

Marzo 28, 2018
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

NEWARK, N.J. -  Valerie A. Nickerson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, and Craig Carpenito, U.S. Attorney for the District of New Jersey announced a New York man and a New Jersey woman today pleaded guilty to their roles in a cross-country conspiracy to distribute dangerous designer drugs over the internet, including a synthetic opioid that is several times more potent than morphine.

Brian Parker, 34, of Long Island City, New York, and Victoria Koleski, 30, of Farmingdale, New Jersey, pleaded guilty before U.S. District Judge William H. Walls to separate informations charging them each with one count of conspiring to distribute controlled substance analogues, and one count of distributing and possessing with intent to distribute controlled substance analogues.

Controlled substance analogues are designer drugs that have chemical structures and hallucinogenic effects similar to Schedule I controlled substances.

Parker admitted that from May 16, 2016 through Aug. 3, 2017, he conspired with others to distribute the controlled substance analogues U-47700, a synthetic opioid several times more potent than morphine, and A-PHP and 3-MEO-PCP, which have chemical structures and hallucinogenic properties similar to A-PVP and PCP, respectively.

Parker manufactured and distributed these drugs and other illegal chemicals through two internet-based companies he controlled, Unbeatablechems and RC Powders. Parker admitted that on May 16, 2016, he distributed U-47700 to a customer in Madison, Wisconsin, which resulted in the death of that individual on May 22, 2016.

Parker used other conspirators, such as Koleski, to send and receive packages for his narcotics distribution business. Those conspirators received raw materials from China or elsewhere through the mail, repackaged and sent them to Parker, who then manufactured those materials into the chemicals that he sold online. Afterwards, Parker transported the finished products back to his conspirators, who then shipped them to Parker's customers.

Koleski admitted that from December 2016 through August 2017, she conspired with Parker to distribute controlled substance analogues. She also admitted that from June 30, 2017 through July 5, 2017, she shipped multiple parcels from a Farmingdale post office that contained controlled substance analogues A-PHP and 3-MEO-PCP.

Both charges in the informations carry a maximum potential penalty of 20 years in prison and a $1 million fine. Sentencing for Parker and Koleski is scheduled for July 2, 2018 and July 3, 2018, respectively.

U.S. Attorney Carpenito credited special agents and task force officers with the Drug Enforcement Administration, under the direction of Special Agent in Charge Valerie A. Nickerson, and postal inspectors of the U.S. Postal Inspection Service, under the direction of Acting Inspector in Charge Ruth M. Mendonca, with the investigation.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Towanda Thorne-James Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster